Form 4 for FTV Fortive
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0001659166-24-000163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-05 | 2024-11-01 | FTV | Walker Stacey A. | SVP - Human Resources | M - OptEx | $58.03 | +171.8K | 128.6K | New | +$9.97M |
| D | 2024-11-05 | 2024-11-01 | FTV | Walker Stacey A. | SVP - Human Resources | S - Sale+OE | $71.71 | -171.8K | 42.7K | -80% | -$12.32M |
| DM | 2024-11-05 | 2024-11-01 | FTV | Walker Stacey A. | SVP - Human Resources | M - OptEx | $0.00 | -171.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | M | A | 32,367 | $67.85 | 160,937 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-01 | M | A | 32,234 | $47.61 | 97,983 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-01 | M | A | 21,795 | $35.38 | 65,749 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-01 | M | A | 1,303 | $35.84 | 43,954 | D | — | — | |
| 5 | Common | Common Stock | 2024-11-01 | S | D | 171,808 | $71.71 | 42,651 | D | — | — | (F1) The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.67 to $71.89. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 6 | Common | Common Stock | 2024-11-01 | M | A | 14,090 | $67.64 | 214,459 | D | — | — | |
| 7 | Common | Common Stock | 2024-11-01 | M | A | 39,432 | $63.85 | 200,369 | D | — | — | |
| 8 | Common | Common Stock | 2024-11-01 | M | A | 30,587 | $63.76 | 128,570 | D | — | — | |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-01 | M | D | 14,090 | $0.00 | 14,090 | D | $67.64 · — to 2031-02-24 | 14,090 Common Stock | (F5) One half of the options granted vest on each of the third and fourth anniversary of the grant date. |
| 10 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-01 | M | D | 39,432 | $0.00 | 19,720 | D | $63.85 · — to 2030-02-20 | 39,432 Common Stock | (F4) One third of the options granted vest on each of the third, fourth, and fifth anniversary of the grant date. The total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020. |
| 11 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-01 | M | D | 32,367 | $0.00 | 0 | D | $67.85 · — to 2029-02-25 | 32,367 Common Stock | (F4) One third of the options granted vest on each of the third, fourth, and fifth anniversary of the grant date. The total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020. |
| 12 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-01 | M | D | 30,587 | $0.00 | 0 | D | $63.76 · — to 2028-02-22 | 30,587 Common Stock | (F4) One third of the options granted vest on each of the third, fourth, and fifth anniversary of the grant date. The total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020. |
| 13 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-01 | M | D | 32,234 | $0.00 | 0 | D | $47.61 · — to 2027-02-23 | 32,234 Common Stock | (F4) One third of the options granted vest on each of the third, fourth, and fifth anniversary of the grant date. The total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020. |
| 14 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-01 | M | D | 21,795 | $0.00 | 0 | D | $35.38 · — to 2026-02-24 | 21,795 Common Stock | (F3) Prior to the Separation, one-fifth of the stock options issued by Danaher on February 24, 2016 ("2016 Danaher Options") to the Reporting Person became exercisable on each of the first five anniversaries of the grant date. In connection with the Separation, the 2016 Danaher Options that remained outstanding as of July 2, 2016 were converted into stock options to purchase 18,120 shares of the Issuer's common stock with identical vesting schedule. In addition, the total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020. |
| 15 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-01 | M | D | 1,303 | $0.00 | 0 | D | $35.84 · — to 2025-07-15 | 1,303 Common Stock | (F2) Prior to the separation of the Issuer from Danaher Corporation ("Danaher") on July 2, 2016 (the "Separation"), one-fifth of the stock options issued by Danaher on July 15, 2015 ("2015 Danaher Options") to the Reporting Person became exercisable on each of the first five anniversaries of the grant date. In connection with the Separation, the 2016 Danaher Options that remained outstanding as of July 2, 2016 were converted into stock options to purchase 1,083 shares of the Issuer's common stock with identical vesting schedule. In addition, the total number of stock options and the exercise price reflect an anti-dilution adjustment applied as a result of the spin-off of Vontier Corporation from the Issuer on October 9, 2020. |